A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping

Autor: Alessandro Serretti, Julien Mendlewicz, Alexander Kautzky, Gianluigi Forloni, Diego Albani, Panagiotis Ferentinos, Siegfried Kasper, Daniel Souery, Chiara Fabbri, Joseph Zohar, Dan Rujescu, Stuart Montgomery, Rudolf Uher, Cathryn M. Lewis
Přispěvatelé: Fabbri C., Kasper S., Kautzky A., Zohar J., Souery D., Montgomery S., Albani D., Forloni G., Ferentinos P., Rujescu D., Mendlewicz J., Uher R., Lewis C.M., Serretti A.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Exome sequencing
Oncology
DISORDER
Genome-wide association study
Antidepressant
VARIANTS
Genome
Depressive Disorder
Treatment-Resistant

0302 clinical medicine
RARE
Physiopsychologie et psychologie biologique [psychiatrie]
IMPUTATION
Exome
0303 health sciences
Depression
treatment-resistant depression
exome sequencing
genome-wide association study
pathway
antidepressant
polygenic prediction
predictive modeling
ASSOCIATION
3. Good health
Psychiatry and Mental health
TREATMENT-RESISTANT DEPRESSION
Major depressive disorder
BURDEN
medicine.medical_specialty
Genotype
Predictive markers
Article
lcsh:RC321-571
Pharmacological treatment
Cellular and Molecular Neuroscience
03 medical and health sciences
Internal medicine
Genetic model
Exome Sequencing
medicine
Humans
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
Gene
Genotyping
Biological Psychiatry
030304 developmental biology
Depressive Disorder
Major

business.industry
Physique
Astronomie
medicine.disease
TAR-ASTERISK-D
030227 psychiatry
ANTIDEPRESSANT RESPONSE
business
Pharmacogenomics
Treatment-resistant depression
030217 neurology & neurosurgery
Imputation (genetics)
Psychiatrie
Zdroj: Translational Psychiatry, 10 (1
Translational Psychiatry
Fabbri, C, Kasper, S, Kautzky, A, Zohar, J, Souery, D, Montgomery, S, Albani, D, Forloni, G, Ferentinos, P, Rujescu, D, Mendlewicz, J, Uher, R, Lewis, C M & Serretti, A 2020, ' A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping ', Translational psychiatry, vol. 10, no. 1, 50 . https://doi.org/10.1038/s41398-020-0738-5
Translational Psychiatry, Vol 10, Iss 1, Pp 1-12 (2020)
Popis: Treatment-resistant depression (TRD) occurs in ~30% of patients with major depressive disorder (MDD) but the genetics of TRD was previously poorly investigated. Whole exome sequencing and genome-wide genotyping were available in 1209 MDD patients after quality control. Antidepressant response was compared to non-response to one treatment and non-response to two or more treatments (TRD). Differences in the risk of carrying damaging variants were tested. A score expressing the burden of variants in genes and pathways was calculated weighting each variant for its functional (Eigen) score and frequency. Gene-based and pathway-based scores were used to develop predictive models of TRD and non-response using gradient boosting in 70% of the sample (training) which were tested in the remaining 30% (testing), evaluating also the addition of clinical predictors. Independent replication was tested in STAR*D and GENDEP using exome array-based data. TRD and non-responders did not show higher risk to carry damaging variants compared to responders. Genes/pathways associated with TRD included those modulating cell survival and proliferation, neurodegeneration, and immune response. Genetic models showed significant prediction of TRD vs. response and they were improved by the addition of clinical predictors, but they were not significantly better than clinical predictors alone. Replication results were driven by clinical factors, except for a model developed in subjects treated with serotonergic antidepressants, which showed a clear improvement in prediction at the extremes of the genetic score distribution in STAR*D. These results suggested relevant biological mechanisms implicated in TRD and a new methodological approach to the prediction of TRD.
SCOPUS: ar.j
info:eu-repo/semantics/published
Databáze: OpenAIRE